Scleroderma News and Research

Latest Scleroderma News and Research

Promedior initiates Phase 1b clinical study of PRM-151 in patients with IPF

Promedior initiates Phase 1b clinical study of PRM-151 in patients with IPF

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Vitamin D deficiency could be linked to development of certain autoimmune lung diseases

Vitamin D deficiency could be linked to development of certain autoimmune lung diseases

CHMP recommends to grant marketing authorization for Espriet drug against PF to CPF

CHMP recommends to grant marketing authorization for Espriet drug against PF to CPF

Special Surgery investigators to present future of clinical care at ACR annual meeting

Special Surgery investigators to present future of clinical care at ACR annual meeting

NEW ANA testing does not diagnose disorder in 40% of scleroderma patients

NEW ANA testing does not diagnose disorder in 40% of scleroderma patients

New iPSC cell lines could help in treating patients with lung diseases

New iPSC cell lines could help in treating patients with lung diseases

Amira initiates AM152 Phase 1 clinical study for fibrotic diseases

Amira initiates AM152 Phase 1 clinical study for fibrotic diseases

Jefferson researchers progress in understanding mechanism behind systemic fibrotic disorder

Jefferson researchers progress in understanding mechanism behind systemic fibrotic disorder

CPF honors three critical areas of leadership for Pulmonary Fibrosis community

CPF honors three critical areas of leadership for Pulmonary Fibrosis community

Amira submits IND application for AM152 antagonist

Amira submits IND application for AM152 antagonist

New federal funds to create first national patient registry for pulmonary fibrosis

New federal funds to create first national patient registry for pulmonary fibrosis

FDA guides Apricus Bio on RayVa's approvability for Raynaud's syndrome secondary to scleroderma

FDA guides Apricus Bio on RayVa's approvability for Raynaud's syndrome secondary to scleroderma

Researchers to conduct gene analysis for ankylosing spondylitis

Researchers to conduct gene analysis for ankylosing spondylitis

Promedior initiates PRM-151 Phase 2a clinical study in prevention of scarring post glaucoma filtration surgery

Promedior initiates PRM-151 Phase 2a clinical study in prevention of scarring post glaucoma filtration surgery

FDA approves brand name VELETRI for Actelion's epoprostenol for injection therapy

FDA approves brand name VELETRI for Actelion's epoprostenol for injection therapy

CPF continues partnership with American Thoracic Society to fund Pulmonary Fibrosis research

CPF continues partnership with American Thoracic Society to fund Pulmonary Fibrosis research

CPF urges people to consider clinical trials for pulmonary fibrosis

CPF urges people to consider clinical trials for pulmonary fibrosis

CPF announces nationwide advertising campaign to increase awareness about PF

CPF announces nationwide advertising campaign to increase awareness about PF

Research findings link some autoimmune disorders with cancer

Research findings link some autoimmune disorders with cancer